Chemed (CHE) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Chemed Corporation  (NYSE: CHE)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Chemed's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Chemed's ROA in the third quarter of 2026?
Chemed Corporation achieved a return on average assets (ROA) of 17.88 % in its third quarter of 2026, this is above CHE's average return on assets of 15.68%.
Chemed Corporation assets over the 12 months ending in its third quarter of 2026 are valued at $1,580 million

ROA has improved compared to 17.67% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 54 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 318, from total ROA ranking in the second quarter of 2026 at 359.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 5.84 % -9.93 % -12.23 % -0.41 % -0.92 %
Y / Y Net Income Change 11.54 % 28.98 % -7.6 % -15.02 % -15.23 %
Net Income (TTM) in million 282 275 260 265 279
Return On Assets (TTM) 17.88 % 17.67 % 16.25 % 16.06 % 16.87 %
CHE's Total Ranking # 318 # 359 # 307 # 292 # 276
Total Assets (TTM) in million 1,718 1,547 1,515 1,538 1,624
Seq. Total Assets Change 11.07 % 2.1 % -1.49 % -5.26 % -5.49 %
Seq. Net Income Change 5.83 % 2.11 % -13.61 % 19.48 % 22.37 %

CHE's 5 Years Annual ROA >> Back to CHE Management Effectiveness >> Compare CHE ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 0
Sector # 55
Overall # 273

Return On Assets Statistics
High Average Low
23.79 %
15.68 %
7.64 %
(Dec 31 2020)   (Jun 30 2017)





Financial Statements
Chemed's Assets $ 1,718 million CHE's Balance sheet
Chemed's Income $ 72 million Quarterly CHE's Income Statement
CHE's Income by Division See CHE's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -0.41 % 0.03 % 17.91 % 7.38 % -7.17 %
Total Assets in million 1,538 1,544 1,544 1,310 1,220
Y / Y Net Income Change -12.17 % 10.82 % 9.17 % -7.05 % -15.94 %
Net Income in million 265 302 273 250 269
Annual Return On Assets 17.24 % 19.55 % 17.65 % 19.06 % 22.02 %

CHE's 5 Years Annual ROA >> Back to CHE Management Effectiveness >> Compare CHE ROA to its Competitors



Comment on CHE's ROA in the fiscal year ending 2025
In the fiscal year 2025 Chemed's ROA decreased compared to previous year to 17.24 %, due to deterioration of net income -12.17 % to $265.24 million, from $302.00 million a year ago, as CHE's assets were $1,538.19 million.


More Return On Assets Ratios
CHE's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CHE's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CHE's Competitors
Subscribers only: Roa for Chemed's Suppliers
Subscribers only: Return On Assets for CHE's Customers

You may also want to know
CHE's Roi CHE's Inventory Turnover Ratio CHE's Growth Rates CHE's Dividend Comparisons
CHE's Profitability Ratios CHE's Asset Turnover Ratio CHE's Dividend Growth
CHE's Roe CHE's Valuation Ratios CHE's Financial Strength Ratios CHE's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Alnylam Pharmaceuticals Inc   46.08 %
Ironwood Pharmaceuticals inc   42.53 %
Aurinia Pharmaceuticals Inc   40.63 %
Nurix Therapeutics Inc   38.61 %
Indivior Pharmaceuticals Inc   36.35 %
Rallybio Corporation  34.55 %
Idexx Laboratories Inc  34.05 %
Zevra Therapeutics Inc   26.33 %
Caredx Inc   25.74 %
Medpace Holdings Inc   24.47 %
Acadia Pharmaceuticals Inc   21.60 %
Standard Biotools Inc   21.56 %
Eli Lilly And Company  21.24 %
Iradimed Corporation  20.89 %
Resmed Inc   18.67 %
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %

Date modified: 2026-10-30T13:05:44+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.